Human Papillomavirus (HPV) ACIP Vaccine Recommendations

as Published in Morbidity and Mortality Weekly Report (MMWR)

CURRENT HPV Vaccine Recommendations

• Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices MMWR. 2016;65(49);1405-8.
  Print version [4 pages]
• Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices MMWR. 2015;64(11);300-304.
  Print version [5 pages]
• MMWR, August 29, 2014, Vo1 63, #RR05
  Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  Print version [36 pages]
• See also:
  • ACIP-VFC Resolution

ARCHIVED HPV Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, December 23, 2011, Vo1 60, #50
  Policy Note: Use of HPV4 in Males
  Print version [1.08MB, 32 pages]
  • GRADE Tables
• MMWR, May 28, 2010, Vo1 59, #20
  Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from ACIP
  Print version [1.33MB, 36 pages]
• MMWR, May 28, 2010, Vo1 59, #20
  FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from ACIP
  Print version [1.33MB, 36 pages]
• MMWR, March 23, 2007, Vo1 56, #RR02
  Quadrivalent Human Papillomavirus Vaccine: Recommendations of ACIP
  Print version [32 pages]

Top of Page